The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Octinoxate, Octisalate, Oxybenzone, Octocrylene, Avobenzone · AVOBENZONE 2 mg/g; OCTINOXATE 7.5 mg/g; OXYBENZONE 5 mg/g; OCTOCRYLENE 2.2 mg/g; OCTISALATE 5 mg/g · Cream · Topical · Revlon Consumer Products Corp
NDC 10967-0688-17 · 1 g in 1 JAR · OTC MONOGRAPH DRUG · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Revlon Consumer Products Corp | AVOBENZONE 2 mg/g; OCTINOXATE 7.5 mg/g; OXYBENZONE 5 mg/g; OCTOCRYLENE 2.2 mg/g; OCTISALATE 5 mg/g | Jul 22, 2026 | Sep 2, 2026 |
| Revlon Consumer Products Corp | AVOBENZONE 2 mg/g; OCTINOXATE 7.5 mg/g; OCTISALATE 5 mg/g; OCTOCRYLENE 2.2 mg/g; OXYBENZONE 5 mg/g | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Prevage Anti-aging Moisture Cream — NDC 10967-0688-17," retrieved September 3, 2026, https://drugdashboards.com/drug/10967068817.
Free to cite with attribution — see how the data is put together.